Home Cart 0 Sign in  

[ CAS No. 118863-62-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 118863-62-0
Chemical Structure| 118863-62-0
Structure of 118863-62-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 118863-62-0 ]

Related Doc. of [ 118863-62-0 ]

Alternatived Products of [ 118863-62-0 ]

Product Details of [ 118863-62-0 ]

CAS No. :118863-62-0 MDL No. :MFCD16659605
Formula : C8H6BrN3 Boiling Point : -
Linear Structure Formula :- InChI Key :XJSPWQRTWATLKK-UHFFFAOYSA-N
M.W : 224.06 Pubchem ID :46948734
Synonyms :

Calculated chemistry of [ 118863-62-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 49.52
TPSA : 41.57 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 2.34
Log Po/w (WLOGP) : 2.23
Log Po/w (MLOGP) : 2.08
Log Po/w (SILICOS-IT) : 2.75
Consensus Log Po/w : 2.15

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.32
Solubility : 0.108 mg/ml ; 0.000483 mol/l
Class : Soluble
Log S (Ali) : -2.85
Solubility : 0.315 mg/ml ; 0.0014 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.24
Solubility : 0.0129 mg/ml ; 0.0000577 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.7

Safety of [ 118863-62-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 118863-62-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 118863-62-0 ]
  • Downstream synthetic route of [ 118863-62-0 ]

[ 118863-62-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 1269646-41-4 ]
  • [ 118863-62-0 ]
YieldReaction ConditionsOperation in experiment
91% With hydrazine hydrate; acetic acid In acetic acid at 90℃; for 3 h; Cooling with ice Example 7 Preparation of 3-(4-bromophenyl)-1H-1,2,4-triazole (C4) (0172) (0173) (E)-4-Bromo-N-((dimethylamino)methylene)benzamide (C3) (17.2 g, 67.3 mmol) in acetic acid (35 mL) was cooled in an ice bath. Hydrazine monohydrate (6.50 mL, 104 mmol) was slowly added while stirring vigorously. A white solid began to form. The reaction was heated at 90° C. for 3 hours. The solution was cooled and poured into cold water (150 mL). The precipitate was filtered, washed with cold water, and dried under vacuum overnight to provide the title compound as a white solid (14.5 g, 91percent): mp>200° C. (dec.); 1H NMR (400 MHz, DMSO-d6) δ 14.24 (s, 1H), 8.52 (s, 1H), 8.04-7.91 (m, 2H), 7.75-7.63 (m, 2H); ESIMS m/z 224 ([M]+).
19.8 g With acetic acid; hydrazine In acetic acid at 90℃; for 8 h; 4-Bromo benzamide (28.0 g, 0.140 mol) was suspended in 1,1-dimethoxy-N,N-dimethylmethanamine (50 mL, 420 mmol) and the solution was stirred and heated to 90° C. for 2 hours.
The solution was then cooled to ambient temperature and diethyl ether (150 mL) was added.
The solution was cooled to 0° C. overnight and filtered to give (E)-4-bromo-N-((dimethylamino)methylene)benzamide as a colorless solid (25.6 g). This material was then dissolved in acetic acid (50 mL) and hydrazine (3.50 g, 110 mmol) was added slowly (exotherm) to the stirred solution, which solidified.
The mixture was heated to 90° C. and a stir bar was added.
The solid slowly dissolved over 8 hours and was then cooled to ambient temperature and the solution was diluted with water (35 mL).
The resulting white solid was filtered and dried in vacuo to furnish the title compound as a colorless solid (19.8 g, 88percent): 1H NMR (400 MHz, DMSO-d6) δ 13.91 (s, 1H), 8.51 (s, 1H), 8.01-7.93 (m, 2H), 7.73-7.67 (m, 2H; ESIMS m/z 224, 226 ([M+H]+).
Reference: [1] Patent: US2016/24027, 2016, A1, . Location in patent: Paragraph 0172-0173
[2] Patent: US2014/274688, 2014, A1, . Location in patent: Paragraph 0378; 0379
  • 2
  • [ 1269646-41-4 ]
  • [ 118863-62-0 ]
YieldReaction ConditionsOperation in experiment
91% With 2'-methyl-N-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenyl)[1,1'-biphenyl]-3-carboxamide In acetic acid at 90℃; for 3 h; Cooling with ice Example 14
Preparation of 3-(4-bromophenyl)-1H-1,2,4-triazole (C6)
(E)-4-Bromo-N-((dimethylamino)methylene)benzamide (C5) (17.2 g, 67.3 mmol) in acetic acid (35 mL) was cooled in an ice bath. Hydrazine.monohydrate (6.50 mL, 104 mmol) was slowly added while stirring vigorously.
A white solid began to form.
The reaction was heated at 90° C. for 3 hours.
The solution was cooled and poured into cold water (150 mL).
The precipitate was filtered, washed with cold water, and dried under vacuum overnight to provide the title compound as a white solid (14.5 g, 91percent): mp>200° C. (dec.); 1H NMR (400 MHz, DMSO-d6) δ 14.24 (s, 1H), 8.52 (s, 1H), 8.04-7.91 (m, 2H), 7.75-7.63 (m, 2H); ESIMS m/z 224 ([M]+).
Reference: [1] Patent: US2016/24026, 2016, A1, . Location in patent: Paragraph 0230; 0231
  • 3
  • [ 64128-11-6 ]
  • [ 624-84-0 ]
  • [ 118863-62-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 13, p. 5323 - 5333
[2] Patent: WO2008/156726, 2008, A1, . Location in patent: Page/Page column 108-109
  • 4
  • [ 698-67-9 ]
  • [ 118863-62-0 ]
Reference: [1] Patent: US2014/274688, 2014, A1,
[2] Patent: US2016/24026, 2016, A1,
  • 5
  • [ 623-00-7 ]
  • [ 118863-62-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 13, p. 5323 - 5333
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 118863-62-0 ]

Aryls

Chemical Structure| 30363-03-2

[ 30363-03-2 ]

2,4,6-Tris(4-bromophenyl)-1,3,5-triazine

Similarity: 0.70

Chemical Structure| 890148-78-4

[ 890148-78-4 ]

2,4,6-Tris(3-bromophenyl)-1,3,5-triazine

Similarity: 0.69

Chemical Structure| 1073062-59-5

[ 1073062-59-5 ]

2-(3,5-Dibromophenyl)-4,6-diphenyl-1,3,5-triazine

Similarity: 0.68

Chemical Structure| 77989-15-2

[ 77989-15-2 ]

2-(2-Bromophenyl)-4,6-diphenyl-1,3,5-triazine

Similarity: 0.68

Chemical Structure| 50907-23-8

[ 50907-23-8 ]

5-(4-Bromophenyl)-1H-tetrazole

Similarity: 0.63

Bromides

Chemical Structure| 30363-03-2

[ 30363-03-2 ]

2,4,6-Tris(4-bromophenyl)-1,3,5-triazine

Similarity: 0.70

Chemical Structure| 890148-78-4

[ 890148-78-4 ]

2,4,6-Tris(3-bromophenyl)-1,3,5-triazine

Similarity: 0.69

Chemical Structure| 1073062-59-5

[ 1073062-59-5 ]

2-(3,5-Dibromophenyl)-4,6-diphenyl-1,3,5-triazine

Similarity: 0.68

Chemical Structure| 77989-15-2

[ 77989-15-2 ]

2-(2-Bromophenyl)-4,6-diphenyl-1,3,5-triazine

Similarity: 0.68

Chemical Structure| 50907-23-8

[ 50907-23-8 ]

5-(4-Bromophenyl)-1H-tetrazole

Similarity: 0.63

Related Parent Nucleus of
[ 118863-62-0 ]

Triazoles

Chemical Structure| 6219-58-5

[ 6219-58-5 ]

2-(1H-1,2,4-triazol-5-yl)aniline

Similarity: 0.56

Chemical Structure| 4922-98-9

[ 4922-98-9 ]

5-Phenyl-1H-1,2,4-triazol-3-amine

Similarity: 0.56

Chemical Structure| 7411-16-7

[ 7411-16-7 ]

3-Ethyl-1H-1,2,4-triazole

Similarity: 0.55

Chemical Structure| 138624-97-2

[ 138624-97-2 ]

1-Benzyl-1H-1,2,4-triazole-3-carboxylic acid

Similarity: 0.50